Outset Medical (NSDQ:OM) announced today that it appointed Jean-Olivier Racine as its new chief technology officer. Racine, a veteran of more than two decades in the technology industry, previously worked as the head of engineering and science for Amazon Web Services (AWS) Health AI, where he managed Amazon Comprehend Medical, Amazon HealthLake and more health […]
Personnel Moves
Accuray promotes exec Suzanne Winter to president
Accuray (NSDQ:ARAY) announced that it promoted executive Suzanne Winter to president, effective as of July 1, 2021. Winter, who previously served as Sunnyvale, Calif.-based Accuray’s chief commercial officer and SVP of R&D & medical & scientific affairs, will continue to report to CEO Joshua Levine. “Suzanne has had a significant impact on Accuray’s product portfolio […]
Glytec names Nausheen Moulana as chief technology officer
Cloud-based insulin management software developer Glytec announced today that it appointed Nausheen Moulana as its chief technology officer. In the role of CTO, Moulana will be responsible for Glytec’s product and technology vision, strategy and execution. She will lead the company’s product development teams — focusing on enhancements in provider workflows, electronic health record (EHR) integrations, mobile […]
Invo Bioscience names chief financial officer
Invo Bioscience (OTCQB:IVOB) today announced that it has appointed Andrea Goren as CFO. Goren has more than 27 years of experience in finance. He has held a number of leadership roles at Phoenix Group, Shamrock Group and Madison Capital Group. “Andrea has been serving Invo over the past year in a consulting capacity and thus […]
Inogen appoints BD veteran as chief medical officer
Inogen (NSDQ:INGN) this week announced that it has appointed Dr. Stanislav Glezer as EVP and chief medical officer, effective June 21. Glezer joins the Goleta, Calif.–based oxygen therapy technology company after a stint as worldwide VP of medical affairs for diabetes care at BD. Prior to BD, he served as chief medical officer at Adocia […]
Zimmer Biomet expands executive slots with Medtronic, UnitedHealth Group veterans
Zimmer Biomet (NYSE:ZBH) today said it has appointed Wilfred van Zuilen as president of Europe, Middle East, Africa, and Dr. Nitin Goyal as chief science, technology, and innovation officer. “It is an exciting time at Zimmer Biomet as we continue to build out our Executive Team to ensure we have the proven, strategic leadership in […]
Carbon Health acquires Steady Health and its diabetes platform
Carbon Health announced today that it acquired Steady Health and its platform for using continuous glucose monitoring to personalize diabetes care. San Francisco-based Carbon Health said in a news release that the acquisition accelerates its rollout of a new primary care model designed to integrate its clinic footprint with virtual and hardware-enabled capabilities to create […]
iRhythm CEO Mike Coyle steps down for personal reasons, stock slides
iRhythm Technologies (NSDQ:IRTC) announced that president & CEO Mike Coyle has resigned due to personal matters. San Francisco-based iRhythm said in a news release yesterday evening that CFO Douglas Devine will take over as interim CEO while the search for a permanent replacement for Coyle is conducted. The company’s board of directors formed a CEO […]
Outset Medical appoints Edwards Lifesciences exec Katie Szyman to board of directors
Outset Medical (NSDQ:OM) announced that it appointed Edwards Lifesciences executive Katie Szyman to its board of directors. Szyman currently serves as corporate VP & GM of critical care at Edwards, having spent more than 30 years in leadership roles in the medtech space, according to a news release. Much of her experience came in 23 […]
Titan Medical names strategy VP
Titan Medical (TSX:TMD;OTC:TITFX) announced today that it appointed Deepak Basra as its VP of strategy and business development. In the newly created role, Basra’s responsibilities include overseeing Toronto-based Titan’s corporate development and strategic planning, according to a news release. Basra joins the company as a veteran of more than 20 years in global business development […]
Timberlake appointed as Berkshire Biomedical CEO
Berkshire Biomedical announced today that it appointed John E. Timberlake as its new president and CEO. Dallas-based Berkshire Biomedical, which develops a virtual care prescription drug delivery and management system, also added Timberlake to its advisory board, according to a news release. Get the full story at our sister site, Drug Delivery Business News.
